Effects of short-term resistance training plus whole-body neuromuscular electrical stimulation on blood cardiometabolic biomarkers in sedentary middle-aged women: a parallel-group, randomized trial Authors: Paulo Vitor Suto Aizava, Vitor de Salles Painelli, Leonardo de Paula Silva, Enzo Berbery Orlandi, Audrei Pavanello, Alexandre Marin Hernandez Cosialls, Kléber Elói Gomes Barbão, Pablo Valdés-Badilla, Braulio Henrique Magnani Branco Published: 2026 ABSTRACT AbstractBackgroundMiddle-aged women are disproportionately affected by cardiometabolic deterioration during the menopausal transition. Resistance training (RT) is an established countermeasure, and whole-body neuromuscular electrical stimulation (WB-NMES) may enhance its physiological effects. However, whether short-term RT combined with WB-NMES further improves blood cardiometabolic biomarkers in this population remains unknown.MethodsIn this parallel-group, randomized trial, 23 sedentary middle-aged women (47 ± 6 y, 86.3 ± 15.7 kg, 1.61 ± 0.06 m, 33.2 ± 6.0 kg∙m2) were allocated to six weeks of RT combined with WB-NMES (RT + WB-NMES; n = 11) or RT alone (RT; n = 12), performing two supervised sessions per week. Primary outcomes were blood biomarkers related to cardiometabolic risk (total cholesterol, LDL-c, HDL-c, VLDL-c, triglycerides, fasting glucose, liver enzymes, and C-reactive protein). Secondary outcomes comprised anthropometric measures, body composition, and physical fitness.ResultsNo significant Group × Time interaction was identified for any blood biomarker. A significant main effect of Time was observed for LDL-c (P = 0.002) and total cholesterol (P = 0.001), with post-hoc analyses revealing significant within-group reductions exclusively in the RT + WB-NMES group (LDL-c: P = 0.041, ES = − 1.13; total cholesterol: P = 0.026, ES = − 0.91). No significant Group × Time interaction was found for any anthropometric, body composition, or most physical fitness variables. Lumbar traction strength improved significantly within the RT + WB-NMES group (P = 0.029, ES = 0.99) but not in RT alone (P = 0.569, ES = 0.53).ConclusionsSix weeks of RT combined with WB-NMES accelerated reductions in LDL-c and total cholesterol in sedentary middle-aged women, although statistical superiority over RT alone was not demonstrated. These preliminary findings support the cardiometabolic relevance of short-term RT + WB-NMES, though larger trials are required.Trial registrationU111113186998 https://ensaiosclinicos.gov.br/rg/RBR6zx5zcz. Registered on 10/09/2025.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12905-026-04465-4.Keywords: Electrical stimulation, Resistance training, Middle-aged, Body composition Background Middle age represents a critical window for the deterioration of cardiometabolic health in women [1]. Progressive hormonal changes associated with the menopausal transition promote visceral fat accumulation, atherogenic dyslipidaemia, and impaired glycaemic control, while simultaneously accelerating the loss of skeletal muscle mass [2], a process that compounds metabolic dysfunction and reduces resting energy expenditure [3, 4]. Such changes result in an increase in the risk of cardiovascular disease, type 2 diabetes mellitus, and metabolic syndrome during the fourth and fifth decades of life [5]. Exercise training represents one of the most effective non-pharmacological approaches to counteract this mainframe, with systematic evidence documenting consistent improvements in lipid profile, fasting glucose, insulin sensitivity, and inflammatory markers following structured programs in previously sedentary populations [6]. Among the possible exercise training modalities, resistance training (RT) has been highlighted as a therapeutic tool in postmenopausal women regarding body composition and cardiometabolic outcomes [7, 8]. Nevertheless, participation in structured RT remains low in this age group [9, 10], and there is ongoing interest in adjunct strategies that can amplify the physiological effects of RT without proportionally increasing mechanical load or session duration. Whole-body neuromuscular electrical stimulation (WB-NMES) has emerged as one such strategy. By superimposing externally generated electrical impulses on voluntary muscle contractions, WB-NMES promotes simultaneous activation of different muscle groups, theoretically recruiting a broader spectrum of motor units, including type II fibres, than voluntary effort alone [11]. This augmented neuromuscular activation is proposed to maximize the acute metabolic and hormonal responses to exercise, with potential downstream effects on muscle protein synthesis, lipolysis, and resting energy expenditure [12, 13]. Systematic reviews and meta-analyses of randomized controlled trials in non-athletic adults confirm that WB-NMES combined with RT produces significant gains in lean body mass and muscle strength, alongside reductions in total and visceral fat [14, 15]. Its comparatively low mechanical load and short session duration also make it a potentially accessible option for individuals facing orthopaedic or motivational barriers to conventional training. The body of evidence has increasingly extended WB-NMES beyond general physical fitness and body composition outcomes to populations with specific clinical needs and to biomarkers of metabolic health. In elderly women at risk for sarcopenia, a 54-week WB-NMES intervention produced meaningful gains in lean mass and functional capacity [16], and in postmenopausal women, WB-NMES-augmented programmes have been associated with improvements in muscle power, gait velocity, and body composition [17]. With respect to cardiometabolic outcomes specifically, recent subanalyses of randomised trials reported favourable effects of WB-NMES on components of metabolic syndrome [18, 19], corroborating the plausibility of blood biomarker responses to this approach. However, the overwhelming majority of published trials have employed intervention periods of ≥ 12 weeks. Whether WB-NMES combined with RT is capable of eliciting detectable and clinically meaningful changes in cardiometabolic biomarkers over substantially shorter timeframes (e.g., ≤ 6 weeks); and whether such changes are superior to those induced by RT alone remains, to our knowledge, an open question. Beyond the issue of intervention length, the existing literature has focused disproportionately on elderly or clinically defined populations; middle-aged women, who carry heightened metabolic vulnerability yet remain functionally capable of robust responses to training, constitute an underrepresented group whose specific responses to short-term WB-NMES-augmented RT have not been established. From a practical standpoint, many sedentary middle-aged women will not, at least initially, commit to RT programs lasting several months. Brief interventions that can be completed and then transitioned into longer programs are valuable in this population. Essentially, evidence that six weeks of RT combined with WB-NMES is sufficient to induce detectable improvements in lipid profiles, glycaemic markers, or liver enzymes would support guidelines on the minimum effective dose of this intervention and help clinicians and practitioners set realistic short-term expectations. Conversely, if favorable biomarker changes require longer exposure, this too constitutes relevant information for program design. Against this background, the present study aimed to evaluate the effects of a six-week RT program combined with WB-NMES on blood biomarkers related to cardiometabolic risk in sedentary middle-aged women. Physical fitness and body composition outcomes were additionally assessed as secondary outcomes to verify the efficacy of the RT program and provide a broader characterization of the physiological responses to the intervention. We hypothesized that six weeks of RT combined with WB-NMES would produce more positive short-term changes in blood cardiometabolic biomarkers than RT alone. Methods Participants The required sample size for this study was estimated using the G*Power software (version 3.1.9.7; Heinrich Heine University, Düsseldorf, Germany). The calculation was based on a two-way repeated-measures ANOVA (within-between interaction) design (i.e., Time × Group) assuming a moderate effect size (F = 0.30) on muscle strength derived from previous studies involving WB-NMES and RT [15]. The parameters used for the calculation were α = 0.05, power (1 − β) = 0.80, and a moderate correlation among repeated measures of 0.6. The total sample size estimated was 20 participants (10 per intervention group). A total of 30 middle-aged women (46.5 ± 6.2 y) were recruited through electronic and social media between September 10 and 20, 2025. The intervention period occurred from October 21 to December 22, 2025, in our university laboratory at Maringá (Paraná, Brazil). To be included, participants had to be women, aged 35–55 years, classified as sedentary (< 150 min·week⁻¹ of moderate-to-vigorous physical activity over the previous 6 months), and not had engaged in structured exercise training during the 6 months preceding enrollment. Participants were required to be free from medical contraindications to exercise as determined by health screening (PAR-Q+) and medical history assessment. Exclusion criteria included: pregnancy; presence of cardiovascular, metabolic, or musculoskeletal conditions limiting exercise participation; pacemaker implantation or other implanted electrical devices; use of medications known to affect neuromuscular function; participation in weight-loss programs; and use of ergogenic or performance-enhancing nutritional supplements within the previous 3 months. Ethical approval for this study was secured from the local Research Ethics Committee (approval number 7.285.433). The trial was registered in the Brazilian Registry of Clinical Trials (ReBEC) under the number RBR-6zx5zcz, available at: https://ensaiosclinicos.gov.br/rg/RBR-6zx5zcz. All procedures adhered to CONSORT guidelines [20]. Written informed consent was obtained from all participants prior to their involvement. Experimental design This study was designed as a parallel-group randomized controlled trial aiming to comprehensively evaluate the effects of a 6-week intervention combining resistance training (RT) and whole-body neuromuscular electrical stimulation (WB-NMES) on cardiometabolic biomarkers in middle-aged women. Participants were randomly assigned in a 1:1 ratio to one of two groups: (1) RT + WB-NMES, which performed resistance training combined with WB-NMES for six weeks; or (2) RT, which performed resistance training alone for the same duration. Randomization was conducted using a computer-generated simple randomization sequence created by an independent researcher with validated statistical software. The allocation sequence was stored in a password-protected digital file and remained inaccessible to all investigators involved in participant recruitment, screening, enrollment, and intervention delivery, thereby ensuring allocation concealment and minimizing selection bias. Due to the nature of the interventions, blinding of participants and exercise professionals was not feasible. However, to reduce detection bias, outcome assessors and the researcher responsible for statistical analyses were blinded to group allocation. An overall attrition rate of 23.3% was observed, attributable to participant withdrawal or failure to achieve the minimum attendance requirement of 85%. Consequently, 23 women completed the study (RT + WB-NMES, n = 11; RT, n = 12) and were included in the final analyses (Fig. 1). Assessments were performed at baseline (MT1; Table 1) and after the 6-week intervention (MT2) to evaluate within- and between-group changes over time. Participants were instructed to maintain their usual daily routines and habitual dietary intake throughout the study period. Experimental design and sample flowchart. Note: n/total = 23; RT Group = Resistance Training Group; RT + WB-NMES Group = Resistance Training + Whole Body Neuromuscular Electrical Stimulation Group Table 1Baseline anthropometric, body composition and physical fitness outcomes of experimental groupsOutcomeRT + WB-NMES (n = 11)RT(n = 12)Total(n = 23)P-valueAnthropometry and body composition Age (years)46 ± 547 ± 747 ± 60.768 Body mass (kg)88.3 ± 14.884.5 ± 16.986.3 ± 15.70.577 Height (m)1.59 ± 0.071.63 ± 0.061.61 ± 0.060.213 BMI (kg∙m²)34.8 ± 6.131.8 ± 5.933.2 ± 6.00.245 Waist circumference (cm)99.8 ± 12.592.9 ± 14.896.2 ± 13.90.238 Abdominal circumference (cm)110.6 ± 14.0104.0 ± 15.9107.2 ± 15.10.304 Hip circumference (cm)116.8 ± 11.8114.1 ± 9.5115.4 ± 10.50.554 Waist-to-Hip ratio0.86 ± 0.110.81 ± 0.080.83 ± 0.100.267 Fat-free mass (kg)46.9 ± 4.847.1 ± 4.747.0 ± 4.70.904 Skeletal muscle mass (kg)25.9 ± 2.826.1 ± 2.826.0 ± 2.70.924 Fat mass (kg)41.4 ± 12.237.4 ± 12.739.3 ± 12.30.452 Body fat (%)46.1 ± 6.743.1 ± 7.044.5 ± 6.90.295Physical fitness Handgrip (kg)26.9 ± 4.825.0 ± 4.325.9 ± 4.50.331 Lumbar traction (kg)58 ± 1556 ± 1157 ± 130.731 30-s Chair stand-up (reps)18 ± 420 ± 619 ± 50.390 Sit-and-reach (cm)24.7 ± 8.125.8 ± 9.425.3 ± 8.60.782 6MWT total distance (m)532 ± 70541 ± 79536 ± 760.779Data are presented as mean ± standard deviation (M ± SD)BMI Body Mass Index Baseline anthropometric, body composition and physical fitness outcomes of experimental groups Data are presented as mean ± standard deviation (M ± SD) BMI Body Mass Index Anthropometric and body composition assessment Body mass (kg) and height (m) were measured following previous recommendations, and body mass index (BMI, kg∙m− 2) was calculated was determined with the formula weight [kg]/height [m2]. Height was recorded to the nearest 0.1 cm using a wall-mounted stadiometer (Welmy R-110®, Santa Bárbara D’Oeste, Brazil) at the end of a normal expiration [21]. Waist circumference, abdominal circumference, and hip circumference were measured using a non-elastic flexible tape to the nearest 0.1 cm, with participants standing upright, barefoot, and with abdomen relaxed. Waist circumference was measured at the midpoint between the lowest rib and the iliac crest. Abdominal circumference was assessed at the level of the umbilicus. Hip circumference was measured at the level of the greatest posterior protuberance of the buttocks. All measurements were obtained at the end of a normal expiration, and the average of two measurements was recorded. If the two measurements differed by more than 0.4 cm, a third measurement was obtained. All measurements were performed by the same trained evaluator. Waist-to-hip ratio was calculated with the formula waist circumference [cm]/hip circumference [cm] [21]. Body mass and body composition were assessed using multifrequency bioelectrical impedance analysis (BIA; InBody 570®, Biospace Co. Ltd., Seoul, South Korea), with a maximum capacity of 250 kg and a measurement precision of 50 g. Standard preassessment guidelines were followed [22], including abstinence from alcohol and caffeine for 48 h, avoidance of vigorous exercise for 24 h, a minimum 4-h fast, no use of diuretics for 7 days, and removal of shoes and heavy clothing during assessment. Measurements were also not performed during menstruation. The following variables were assessed: body mass (kg), fat-free mass (kg), skeletal-muscle mass (kg), fat mass (kg) and body fat percentage (%). Blood biomarkers analysis All participants fasted overnight prior to venous blood collection, which was performed immediately following BIA assessment via venipuncture of an antecubital vein (cephalic, basilic, or median cubital veins) using a 21-gauge butterfly needle (BD Vacutainer Safety-Lok®, BD Biosciences, Australia). Four 4 mL Vacutainer® tubes (BD Biosciences, Australia) were collected, one containing citrate and three containing ethylenediaminetetraacetic acid (EDTA). Samples were centrifuged at 3,600 rpm for 11 min, aliquoted and subsequently stored at − 20 °C until analysis. All samples were batch-analyzed within 24 h of collection, in a blinded fashion, using an Advia 1800 automated analyzer with manufacturer-supplied reagents (Siemens Healthcare Diagnostics, Germany). All analyses were conducted in duplicate by the same researcher. The analyzed biomarkers included glucose, albumin (ALB), alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), triglycerides, total cholesterol, high-density lipoprotein cholesterol (HDL-c), very low-density lipoprotein cholesterol (VLDL-c) and low-density lipoprotein cholesterol (LDL-c). Lactate dehydrogenase (LDH) was additionally analyzed as a surrogate of muscle injury to monitor WB-NMES safety. Physical fitness assessment Before physical fitness assessment, resting blood pressure was measured in a seated position using an automated device (Omron® HEM-7113) [23]. Physical fitness was evaluated through the following tests: (i) 6-minute walk test (6MWT); (ii) sit and reach test; (iii) 30-s chair stand-up test; (iv) handgrip strength; and (v) lumbar traction strength. Each test was separated by a 2-minute interval. The 6MWT [24] was employed to assess walking endurance. Participants were instructed to walk as quickly and safely as possible for six minutes, aiming to cover the greatest distance possible along a 30-meter walkway with turns at each end. The total distance walked during the test was recorded. Flexibility was assessed through the sit-and-reach test performed on a Wells bench (Sanny® BW2002, Sao Paulo, Brazil) [25], with the best performance among 3 attempts being recorded. Lower-body dynamic muscle endurance was determined through the 30-second chair stand-up test [26], in which participants were instructed to stand up and sit down as many times as possible within 30 s, with their arms crossed at the chest level. Maximum isometric strength was assessed through the handgrip and lumbar traction dynamometers [27], with the best performance among 3 attempts being recorded for each device. Resistance training protocol The RT program comprised a total of 12 moderate-intensity sessions performed over 6 weeks, with two sessions per week. Each session lasted approximately 30 min and included a 5-min general warm-up in a treadmill, a 20-min main component, and a 5-min stretching period. The main component alternated between two exercise protocols (A and B) across training sessions. A detailed description of each RT protocol and its respective exercises is outlined in Table 2. The RT structure was designed to stimulate target major muscle groups using paired upper- and lower-body exercises performed consecutively. A 90-s rest interval was applied only after completion of each exercise pair to optimize session duration [28]. Table 2Six-week resistance training programProtocolsTraining ExercisesA1. Leg Curl + Chest Press;2. Isometric Squat + Biceps Curl;3. Split Squat with Trunk Rotation (bilateral);4. Seated Row + Knee-Supported Push-up;5. Deadlift + Reverse Fly (legs elevated);6. Standing Leg Curl + Low-Row;7. Front Plank + Standing Calf Raise;8. Side Plank + Back Extension;B1. Squat + Dumbbell Front Raise;2. Leg Extension + French Press (triceps extension);3. Stiff-Leg Deadlift + Front Raise;4. Knee-Supported Push-Up + Back Extension;5. Reverse Fly with Legs Elevated;6. Standing Leg Curl + Seated Low Row;7. Standing Calf Raise + Bilateral Hip Bridge; Six-week resistance training program 1. Leg Curl + Chest Press; 2. Isometric Squat + Biceps Curl; 3. Split Squat with Trunk Rotation (bilateral); 4. Seated Row + Knee-Supported Push-up; 5. Deadlift + Reverse Fly (legs elevated); 6. Standing Leg Curl + Low-Row; 7. Front Plank + Standing Calf Raise; 8. Side Plank + Back Extension; 1. Squat + Dumbbell Front Raise; 2. Leg Extension + French Press (triceps extension); 3. Stiff-Leg Deadlift + Front Raise; 4. Knee-Supported Push-Up + Back Extension; 5. Reverse Fly with Legs Elevated; 6. Standing Leg Curl + Seated Low Row; 7. Standing Calf Raise + Bilateral Hip Bridge; The RT program followed a progressive structure, with one set of 60 s per exercise pair during week 1, one set of 90 s during weeks 2–4, and one set of 120 s during weeks 5–6. Exercise intensity was individually adjusted using the OMNI perceived exertion scale, with participants instructed to maintain ratings between 4 (‘somewhat easy’) and 5 (‘somewhat hard’). All RT sessions were supervised by certified professionals. Training adherence was monitored through attendance records, and a minimum attendance rate of 85% was required for inclusion in the per-protocol analysis. Intervention fidelity was ensured through standardized intervention manuals and regular meetings among supervising professionals to review protocol compliance and address any deviations. Whole-body neuromuscular electrostimulation (WB-NMES) WB-NMES was applied through a specific software (I-Motion v.25, Madrid, Spain) connected via Bluetooth® to a class 1 commercial vest (I-Motion, Madrid, Spain) equipped with 20 carbon-rubber electrodes, designed to simultaneously stimulate more than 12 muscle groups. The stimulation parameters were set at a frequency of 80 Hz and a pulse duration of 400 µs. The approach comprised a stimulation time of 5 s, with a 0.8-second ramp, followed by an immediate pause of 3 s [29]. Intensities were individualized adjusted for each body region of each participant based on their tolerance to the maximal stimulus, up to a maximum of 90 mA. Statistical analysis All data analyses were performed by a researcher blinded to the interventions and the allocation of participants to the two experimental groups, with data being presented as mean ± standard deviation (M ± SDs). There was no missing data to be handled. After normality was assured through the Shapiro-Wilk test, an unpaired t-test was conducted to assess potential between-group baseline differences. A two-way repeated-measure mixed model was employed to investigate the intervention effect on blood biochemical markers as well as on anthropometric, body composition and physical fitness outcomes, with Time (i.e., MT1 and MT2) and Group (i.e., WB-NMES + RT and RT) as main factors. Participants were the random factor in all analyses. Additionally, the absolute and relative changes between the pre- and post-intervention moments were compared through an unpaired t-test. To quantify the magnitude and precision of the observed effects, effect sizes (ES) and their corresponding 95% confidence intervals (95% CIs) were calculated using Cohen’s d only for the outcomes in which a significant main effect of Time was detected. We classified ES < 0.2 as negligible effect, ES between 0.2 and 0.49 as small effect, ES between 0.50 and 0.79 as moderate effect, and ES ≥ 0.80 as large effect. Data was analyzed through the statistical package SAS v.9.3 and significance was set at p < 0.05. Results Blood biomarkers Blood biomarkers results are presented in Table 3. No significant Group by Time interaction was identified for plasma albumin (P = 0.388), alanine aminotransferase (P = 0.979), aspartate aminotransferase (P = 0.619), gamma glutamil transferase (P = 0.187), glucose (P = 0.654), triglycerides (P = 0.639), HDL-c (P = 0.766), LDL-c (P = 0.468), total cholesterol (P = 0.446), VLDL (P = 0.640), C-reactive protein (P = 0.394) or LDH (P = 0.112). However, a significant main effect of Time was identified for LDL-c (P = 0.002) and total cholesterol (P = 0.001). Post-hoc analyses showed a significant decrease in LDL-c (P = 0.041, ES=-1.13, 95%CI =-2.08 to -0.19) and total cholesterol (P = 0.026, ES=-0.91, 95%CI =-1.83 to -0.01) for RT + WB-NMES, but not for RT alone (respectively, P = 0.232, ES=-0.57, 95%CI=-1.43 to + 0.28; and P = 0.179, ES=-0.70, 95%CI=-1.57 to + 0.16). No significant between-group differences were detected in the absolute or relative changes for any of the blood biomarkers (all P > 0.05). Table 3Blood biochemical markers values in the WB-NMES + RT and RT groups before (MT1) and after (MT2) interventionOutcomesExp. GroupsMeasurement Times(M ± DP)Absolute ChangeRelative ChangeMT1MT2ALB (mg/dL)RT + WB-NMES3.4 ± 0.23.2 ± 0.3-0.1 ± 0.3-4.1 ± 9.3RT3.6 ± 0.33.3 ± 0.3-0.3 ± 0.4-6.9 ± 11.2ALT (mg/dL)RT + WB-NMES16.6 ± 5.116.5 ± 8.1-0.5 ± 7.4-0.4 ± 47.1RT14.1 ± 3.414.0 ± 11.8-0.7 ± 10.8-10.0 ± 98.3AST (mg/dL)RT + WB-NMES22.1 ± 6.422.1 ± 6.30.0 ± 4.20.8 ± 23.8RT19.4 ± 3.621.2 ± 8.81.8 ± 10.416.3 ± 69.1GGT (mg/dL)RT + WB-NMES34.0 ± 13.232.0 ± 11.7-1.1 ± 5.2-2.4 ± 21.9RT28.3 ± 9.533.4 ± 16.15.1 ± 9.817.0 ± 34.3Fasting glucose (mg/dL)RT + WB-NMES85.7 ± 9.183.0 ± 14.4-2.8 ± 15.4-2.7 ± 18.2RT91.1 ± 10.785.8 ± 11.0-5.3 ± 11.0-5.2 ± 11.9Triglycerides (mg/dL)RT + WB-NMES106.4 ± 37.996.0 ± 37.7-10.9 ± 51.3-14.6 ± 24.8RT108.7 ± 43.189.4 ± 35.3-18.1 ± 26.3-15.8 ± 16.8HDL-c (mg/dL)RT + WB-NMES55.8 ± 14.656.3 ± 14.23.1 ± 12.76.8 ± 27.7RT57.3 ± 14.257.2 ± 16.5-0.1 ± 15.42.0 ± 30.2LDL-c (mg/dL)RT + WB-NMES104.8 ± 25.174.9 ± 25.5*-27.3 ± 22.8-26.0 ± 19.9RT105.2 ± 29.587.9 ± 30.1-21.4 ± 37.5-15.6 ± 29.8Total Cholesterol (mg/dL)RT + WB-NMES181.9 ± 28.3152.0 ± 36.9*-28.2 ± 28.6-15.6 ± 14.0RT183.7 ± 28.6165.8 ± 21.7-20.2 ± 31.5-9.5 ± 15.0VLDL-c (mg/dL)RT + WB-NMES21.3 ± 7.619.2 ± 7.6-2.2 ± 10.3-3.9 ± 41.1RT21.8 ± 8.617.9 ± 7.1-3.6 ± 5.3-14.0 ± 17.1C-Reactive Protein (mg/dL)RT + WB-NMES5.8 ± 3.26.2 ± 5.90.5 ± 8.36.4 ± 49.6RT3.3 ± 2.26.3 ± 5.03.5 ± 5.824.0 ± 81.3LDH (mg/dL)RT + WB-NMES305.2 ± 63.1249.7 ± 35.9-47.9 ± 60.7-14.3 ± 15.2RT294.5 ± 48.1290.0 ± 56.8-4.5 ± 77.0-6.7 ± 12.5ALB Albumin, ALT Alanine Aminotransferase, AST Aspartate Aminotransferase, ALP Alkaline Phosphatase, GGT Gamma‒Glutamyl Transferase, HDL-c High-Density Lipoprotein, LDL-c Low-Density Lipoprotein, LDH Lactate DehydrogenaseLegend: The symbol * refers to a statistically significant within-group difference between MT2 and MT1 Blood biochemical markers values in the WB-NMES + RT and RT groups before (MT1) and after (MT2) intervention ALB Albumin, ALT Alanine Aminotransferase, AST Aspartate Aminotransferase, ALP Alkaline Phosphatase, GGT Gamma‒Glutamyl Transferase, HDL-c High-Density Lipoprotein, LDL-c Low-Density Lipoprotein, LDH Lactate Dehydrogenase Legend: The symbol * refers to a statistically significant within-group difference between MT2 and MT1 Anthropometric and body composition outcomes Anthropometric and body composition results are presented in Table 4. No significant Group by Time interaction was identified for body mass (P = 0.716), BMI (P = 0.597), waist circumference (P = 0.965), abdominal circumference (P = 0.580), hip circumference (P = 0.680), waist-to-hip ratio (P = 0.802), fat-free mass (P = 0.436), skeletal muscle mass (P = 0.507), fat mass (P = 0.953) or body fat percentage (P = 0.775) No significant between-group differences were detected in the absolute or relative changes for any of the anthropometric or body composition outcomes (all P > 0.05). Table 4Anthropometric and body composition results in the WB-NMES + RT and RT groups before (MT1) and after (MT2) interventionOutcomesExp. GroupsMeasurement Times(M ± DP)Absolute ChangeRelative ChangeMT1MT2Body Mass (kg)RT + WB-NMES88.3 ± 14.888.2 ± 15.3-0.06 ± 1.41-0.12 ± 1.49RT84.5 ± 16.886.1 ± 16.7-0.29 ± 1.39-0.46 ± 1.68BMI (kg∙m2)RT + WB-NMES34.8 ± 6.134.8 ± 6.2-0.01 ± 0.57-0.05 ± 1.55RT31.8 ± 5.932.1 ± 6.1-0.14 ± 0.53-0.52 ± 1.75Waist Circumference (cm)RT + WB-NMES99.8 ± 12.599.3 ± 13.9-0.50 ± 3.79-0.61 ± 3.80RT92.9 ± 14.794.0 ± 15.1-0.61 ± 2.79-0.75 ± 3.17Abdominal Circumference (cm)RT + WB-NMES110.6 ± 13.9109.5 ± 16.9-1.16 ± 5.12-1.27 ± 4.29RT104.0 ± 15.9103.2 ± 15.5-2.23 ± 3.11-2.00 ± 3.46Hip Circumference (cm)RT + WB-NMES116.8 ± 11.8117.3 ± 12.10.45 ± 1.690.38 ± 1.47RT114.1 ± 9.5115.1 ± 13.90.15 ± 1.570.11 ± 1.39Waist-to-Hip RatioRT + WB-NMES0.86 ± 0.110.85 ± 0.10-0.01 ± 0.03-0.99 ± 3.60RT0.81 ± 0.080.81 ± 0.08-0.01 ± 0.02-0.85 ± 3.20Fat-Free Mass (kg)RT + WB-NMES46.9 ± 4.847.3 ± 4.5+ 0.45 ± 0.811.02 ± 1.71RT47.1 ± 4.747.6 ± 5.1+ 0.18 ± 0.720.35 ± 1.54Skeletal Muscle Mass (kg)RT + WB-NMES25.9 ± 2.926.1 ± 2.7+ 0.21 ± 0.500.88 ± 1.96RT26.1 ± 2.826.3 ± 2.3+ 0.07 ± 0.420.24 ± 1.64Fat Mass (kg)RT + WB-NMES41.4 ± 12.240.9 ± 13.1-0.50 ± 1.42-1.73 ± 3.06RT37.4 ± 12.738.4 ± 12.6+ 0.47 ± 1.49-1.83 ± 5.11Body Fat (%)RT + WB-NMES46.1 ± 6.645.5 ± 7.3-0.64 ± 0.96-1.57 ± 2.10RT43.1 ± 6.943.5 ± 7.2-0.50 ± 1.42-1.42 ± 4.03BMI Body Mass Index Anthropometric and body composition results in the WB-NMES + RT and RT groups before (MT1) and after (MT2) intervention BMI Body Mass Index Physical fitness results are presented in Table 5. No significant Group by Time interaction was identified for the handgrip (P = 0.623), lumbar traction (P = 0.225), 30-S chair stand-up (P = 0.651), sit-and-reach (P = 0.819) or 6MWT (P = 0.941). However, a significant main effect of Time was identified for the lumbar traction test (P = 0.005). Post-hoc analysis showed a significant improvement in lumbar traction test (P = 0.029, ES = 0.99, 95%CI = + 0.07 to + 1.93) for RT + WB-NMES, but not for RT alone (P = 0.569, ES = 0.53, 95% CI =-0.32 to + 1.38). No significant between-group differences were detected in the absolute or relative changes for any of the physical fitness variables (all P > 0.05). Table 5Physical fitness results in the WB-NMES + RT and RT groups before (MT1) and after (MT2) interventionOutcomesExp. GroupsMeasurement Times(M ± DP)Absolute ChangeRelative ChangeMT1MT2Handgrip (kg)RT + WB-NMES26.9 ± 4.827.8 ± 5.0+ 0.9 ± 2.0+ 3.7 ± 8.8RT24.9 ± 4.326.8 ± 3.6+ 1.5 ± 4.0+ 8.1 ± 19.4Lumbar Traction (kg)RT + WB-NMES57.8 ± 14.871.7 ± 13.2*+ 14.0 ± 19.8+ 36.6 ± 66.1RT55.8 ± 10.761.9 ± 9.2+ 5.4 ± 9.0+ 11.4 ± 18.530-s Chair Stand-Up (reps)RT + WB-NMES18 ± 421 ± 6+ 2.5 ± 5.3+ 14.5 ± 29.7RT20 ± 621 ± 5+ 2.0 ± 5.0+ 14.3 ± 29.6Sit-and-Reach (cm)RT + WB-NMES24.7 ± 8.125.5 ± 9.0+ 0.8 ± 6.5+ 6.2 ± 33.1RT25.8 ± 9.424.6 ± 7.6+ 0.5 ± 3.3+ 3.4 ± 18.36MWT Total Distance (m)RT + WB-NMES532 ± 70567 ± 69+ 34.8 ± 40.7+ 7.0 ± 7.9RT541 ± 79567 ± 41+ 35.5 ± 50.5+ 7.9 ± 10.36MWT = 6-minute walking test. The symbol * refers to a significant within-group effect compared to MT1 (at P<0.05) Physical fitness results in the WB-NMES + RT and RT groups before (MT1) and after (MT2) intervention 6MWT = 6-minute walking test. The symbol * refers to a significant within-group effect compared to MT1 (at P<0.05) Discussion The present study investigated the short-term effects of a six-week RT program combined with WB-NMES compared to RT alone on blood cardiometabolic biomarkers, body composition, and physical fitness in sedentary middle-aged women. Our findings suggest that a short-term approach combining RT with WB-NMES may produce early and potentially meaningful relevant changes in lipid profile over RT alone. The most notable finding of the present study was the large significant reduction in LDL-c and total cholesterol following six weeks of RT + WB-NMES, despite the brevity of the intervention. These findings align with a growing body of evidence linking WB-EMS with favorable lipid modifications. Salehi et al. [30] reported significant decreases in total cholesterol, LDL-c, and VLDL-c following WB-EMS in overweight men, while Guretzki et al. [18] and Mendel et al. [19] documented favorable effects on metabolic syndrome components, including lipid-related outcomes, in adults at moderate-to-high cardiometabolic risk. Given that other cardiometabolic blood biomarkers remained unchanged, it is possible that the response to short-term WB-NMES is modulated by other factors explaining the more pronounced lipid response observed in our middle-aged, sedentary cohort, such as participants’ age, training status, or baseline metabolic risk, though this warrants further investigation. It is also worth contextualizing these lipid findings within the hormonal landscape likely characterizing our sample. The perimenopausal transition, consistent with the age range of our participants (35–55 years; mean: 46.5 ± 6.2 y), is associated with progressive estrogen decline that shifts the lipid profile toward greater atherogenicity, including increases in LDL-c and total cholesterol and reductions in HDL-c [31]. In this hormonal context, exercise-induced attenuation of these lipid trajectories might carry particular clinical relevance. From a mechanistic standpoint, the preferential lipid improvements in the RT + WB-NMES group might reflect the augmented neuromuscular activation afforded by superimposed electrical stimulation. WB-NMES promotes simultaneous recruitment of a broader motor unit spectrum, including type I muscle fibres [32], which have a greater reliance on circulating lipids as energy substrates. This intensified multi-muscle activation is proposed to increase post-exercise oxygen consumption and lipolytic enzyme activity, enhancing LDL particle clearance and accelerating cholesterol catabolism via upregulation of hepatic LDL-receptor expression [12, 13]. Such metabolic cascade effects might have been sufficient to produce measurable lipid changes within six weeks, suggesting that the augmented stimulus of RT + WB-NMES may attenuate the threshold for early lipid adaptation when RT alone does not provide an adequate dose. The absence of significant lipid changes in the RT-alone group is coherent with the broader literature. A recent large meta-analysis demonstrated that RT in isolation generally produces smaller and less consistent reductions in LDL-c than combined or aerobic modalities [33]. In this direction, systematic reviews focused on postmenopausal women confirmed that such effects are more reliably observed in participants with dyslipidaemia or obesity at baseline and with sufficiently prolonged interventions [7, 8]. In the present study, the twice-weekly frequency and 12 accumulated sessions may represent a below-threshold stimulus for detectable lipid changes through RT alone, while the progressive addition of WB-NMES may have served as the critical adjunct needed to surpass this metabolic threshold within six weeks, although this hypothesis deserves direct examination in future, larger dose-response trials. The absence of significant changes in the remaining cardiometabolic biomarkers is not unexpected and reflects the time-dependency of metabolic adaptations to exercise training. Triglyceride reductions following RT are more consistently reported in longer interventions or in individuals with elevated baseline concentrations [7], while improvements in fasting glucose and insulin sensitivity typically emerge after ≥ 8–12 weeks of structured training, particularly in populations without pre-existing glycaemic dysregulation [6]. The stability of C-reactive protein across both groups is similarly understandable, as anti-inflammatory responses to exercise are most pronounced in individuals with evidence of chronic low-grade inflammation rather than in non-clinical cohorts such as ours [14]. Additionally, the null findings for albumin and liver enzymes indicate the absence of hepatic stress or functional deterioration, which is reassuring from a safety perspective. Anthropometric and body composition outcomes similarly showed no significant changes, a null finding that was anticipated given the well-established principle that meaningful morphological adaptations require longer training exposure than the six-week period currently employed [34]. Early responses to RT are predominantly characterized by neural adaptations (i.e. enhanced motor unit recruitment, improved neuromuscular coordination, and increased discharge rates) rather than measurable changes in muscle cross-sectional area or whole-body fat depot mobilization [2, 35]. Although WB-NMES augments neural input to working muscles, 12 accumulated sessions appear insufficient to produce detectable differences in fat or lean mass, at least when assessed by BIA, which is corroborated by meta-analytic evidence confirming that body composition improvements attributable to WB-NMES are most frequently reported in interventions lasting ≥ 12 weeks [14, 15]. These findings therefore do not refute the potential long-term efficacy of RT + WB-NMES on anthropometric or body composition; they rather highlight the importance of communicating realistic morphological timelines to sedentary middle-aged women initiating an exercise program. A significant improvement in lumbar traction strength was observed, a potential consequence of WB-NMES vests design, which are specifically configured to simultaneously activate paraspinal and core musculature through trunk and lumbar electrode placement, in addition to peripheral limb muscles [17]. This targeted trunk activation likely complements voluntary muscular effort during RT, producing additive neuromuscular adaptations in the lumbar extensor musculature exceeding the threshold achievable by RT alone within the same timeframe. Lumbar and core muscle groups are particularly amenable to early neuromuscular improvements given their chronic postural engagement and high susceptibility to motor unit recruitment enhancement through superimposed electrical stimulation [36]. In contrast, the absence of significant changes in the remaining physical fitness outcomes is broadly consistent with the expected trajectory of adaptation in previously sedentary women undertaking short-term, moderate-intensity RT. Improvements in cardiorespiratory endurance, global muscular endurance, and flexibility are generally observed after longer and higher-volume programs than those employed in our study [37], with the twice-weekly frequency and 12-session cumulative volume likely representing an insufficient stimulus to induce statistically detectable adaptations across these diverse fitness domains, irrespective of WB-NMES augmentation. A specific concern in the WB-NMES literature is the potential for exercise-induced muscle damage, particularly when untrained individuals are exposed to simultaneous multi-muscle electrical stimulation for the first time [29]. In the present study, LDH, a well-established marker of muscle injury and cellular membrane disruption, did not change significantly in either group over the course of the intervention. This finding supports the safety of the applied WB-NMES protocol when combined with appropriately dosed RT in sedentary middle-aged women. The individualized stimulation intensity (up to 90 mA), the progressive loading structure of the RT program, and the adherence to established WB-NMES safety guidelines [29] likely contributed to the absence of significant change in this muscle damage-related marker. Several limitations must be acknowledged. The modest sample size following attrition (n = 23) constitutes the primary constraint, as statistical power was based muscle strength outcomes, given the absence of meta-analyses directly reporting the effects of WB-NMES on cardiometabolic biomarkers in apparently healthy populations at the time of study design, a necessary proxy that may have rendered the study underpowered to detect statistically significant group × time interactions in biochemical markers, which are additionally subject to considerable intra-individual biological variability. Furthermore, menopausal status was not systematically assessed, and hormonal profiling was not performed. Given that the sample comprised middle-aged women undergoing an age range consistent with the perimenopausal transition, heterogeneity in hormonal status may have introduced uncontrolled variability in lipid and cardiometabolic biomarkers. Future studies should characterize participants’ menopausal status and, where feasible, stratify analyses accordingly. Additionally, although participants were instructed to maintain their habitual dietary intake throughout the study period, adherence to this recommendation was not verified through formal dietary assessment tools, such as food records or 24-hour dietary recalls. Given that lipid concentrations are sensitive to variations in saturated and unsaturated fat intake, and that glucose metabolism is susceptible to differences in total carbohydrate load and dietary glycemic index, unmonitored inter-individual variation in macronutrient composition may have introduced confounding variability in the biochemical outcomes independently of the exercise interventions. In parallel, the absence of a non-exercising control group precludes estimation of the absolute effect of either intervention relative to continued sedentary behavior. Moreover, the relatively short duration of the study prevents inference about whether the within-group changes in LDL-c and total cholesterol represent sustained physiological adaptations or transient responses to the exercise stimulus. The open-label nature of the intervention also introduces a risk of performance bias. Finally, the study was conducted exclusively in previously sedentary middle-aged women, limiting the generalizability of findings to other populations or sexes. Future investigations should employ larger, adequately powered samples with dietary monitoring, include longer follow-up periods, and incorporate dose-response designs to elucidate the optimal WB-NMES parameters for cardiometabolic biomarker modulation. Conclusion In conclusion, the present randomized trial demonstrated that six weeks of twice-weekly RT combined with WB-NMES is sufficient to elicit potentially meaningful reductions in LDL-c and total cholesterol, with large effect sizes, in previously sedentary middle-aged women, a known population at heightened cardiometabolic risk during the menopausal transition. From a clinical and practical standpoint, these findings indicate that sedentary middle-aged women who are unwilling or unable to commit to prolonged exercise programs may still derive early, biologically meaningful cardiometabolic benefits from a short-term RT + WB-NMES protocol. Hence, clinicians and exercise professionals may consider RT + WB-NMES as a feasible entry-point intervention capable of initiating favorable lipid adaptations within as little as six weeks, with potential to serve as a transition toward longer-term structured exercise programs. Supplementary Information Supplementary Material 1. Acknowledgements We thank all participants for their effort. Authors’ contributions Conceptualization: VSP, BHMBData curation: PVSA, LPS, EBO, APFormal analysis: VSP, AMHC, KEGB, PVBFunding acquisition: BHMBInvestigation: VSP, PVSA, LPS, EBO, APMethodology: AMHC, KEGB, PVB, BHMBProject administration: BHMBResources: BHMBSoftware: VSP, PVSASupervision: PVSA, BHMBValidation: VSP, PVSA, LPS, EBO, AP, AMHC, KEGB, PVB, BHMBVisualization: VSP, PVSA, LPS, EBO, AP, AMHC, KEGB, PVB, BHMBWriting – original draft: VSP, PVSA, LPS, EBO, APWriting – review and editing: VSP, AMHC, KEGB, PVB, BHMBAll authors read and approved the final version of the manuscript. Funding This research was supported by scholarships of productivity in research provided by the Araucaria Foundation for Support of Scientific and Technological Development and the Cesumar Institute of Science, Technology and Innovation. Of note, these funding sources were not involved in the design, data collection or interpretation in this study. The Article Processing Charge (APC) for publishing this research was funded by the Coordination for the Improvement of Higher Education Personnel (CAPES) (ROR identifier: 00 × 0ma614). Data availability The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate Informed consent was obtained from all participants included in the study. All experimental procedures were approved by the Ethics Committee of Cesumar University (approval number 7.285.433, in accordance with Resolution No. 466/2012 of the Brazilian National Health Council and with the Helsinki Declaration of 1975 revised in 2024. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1. Data Availability Statement The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.